Peter J. Parker

What is he best known for?

The fields of study he is best known for:

• Gene
• Enzyme
• Phosphorylation

His main research concerns Protein kinase C, Biochemistry, Cell biology, Kinase and Protein kinase A. His research integrates issues of SH3 domain, Molecular biology, Dephosphorylation and MAP2K7 in his study of Protein kinase C. His MAP2K7 research incorporates themes from c-Raf, Cyclin-dependent kinase 9, Mitogen-activated protein kinase kinase, Peptide sequence and MAP kinase kinase kinase.

His work on Signal transduction, Endosome and Pkc isoforms as part of general Cell biology study is frequently linked to Dynamics, therefore connecting diverse disciplines of science. His Kinase research is multidisciplinary, incorporating perspectives in In vitro, GTPase-activating protein, Inositol, Phosphorylation and Allosteric regulation. He has researched Protein kinase A in several fields, including Mitogen-activated protein kinase, Endocrinology, Internal medicine and MAPK/ERK pathway.

His most cited work include:

• Synthesis and Function of 3-Phosphorylated Inositol Lipids (1401 citations)
• The extended protein kinase C superfamily. (1365 citations)
• Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1 (1041 citations)

What are the main themes of his work throughout his whole career to date?

Peter J. Parker mainly investigates Cell biology, Protein kinase C, Biochemistry, Kinase and Protein kinase A. His Cell biology research is multidisciplinary, incorporating elements of Integrin, Cell migration and Cytokinesis. His Protein kinase C research incorporates elements of Molecular biology, Kinase activity and Gene isoform.

His Kinase study combines topics in areas such as In vitro, Mutant and Serine. His Phosphorylation study incorporates themes from Tyrosine kinase and Protein kinase domain. His biological study spans a wide range of topics, including c-Raf and Cyclin-dependent kinase 4.

He most often published in these fields:

• Cell biology (61.21%)
• Protein kinase C (50.91%)
• Biochemistry (43.23%)

What were the highlights of his more recent work (between 2012-2021)?

• Cell biology (61.21%)
• Kinase (30.10%)
• Protein kinase C (50.91%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cell biology, Kinase, Protein kinase C, Cancer research and Phosphorylation. His work deals with themes such as Regulator, Anaphase and Cell polarity, which intersect with Cell biology. Many of his research projects under Kinase are closely connected to PKD1 with PKD1, tying the diverse disciplines of science together.

Protein kinase C is a subfield of Biochemistry that Peter J. Parker studies. His studies in Cancer research integrate themes in fields like Cancer cell, Cancer, Protein kinase B and Diacylglycerol kinase. As part of one scientific family, Peter J. Parker deals mainly with the area of Phosphorylation, narrowing it down to issues related to the Tyrosine kinase, and often Mutation.

Between 2012 and 2021, his most popular works were:

• Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial (282 citations)
• Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial (282 citations)
• Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative orBRCA1/2breast cancer (CRUK/07/012) (155 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Enzyme
• Amino acid

His main research concerns Cell biology, Protein kinase C, Kinase, Phosphorylation and Signal transduction. Peter J. Parker combines subjects such as Autophagy and Regulator with his study of Cell biology. His Protein kinase C study introduces a deeper knowledge of Biochemistry.

His Kinase study combines topics from a wide range of disciplines, such as Gene knockout, NODAL and Mesoderm. His Phosphorylation study integrates concerns from other disciplines, such as Mutation, HEK 293 cells, Protein kinase domain and Cell polarity. His Signal transduction research integrates issues from Cell cycle, RELB, Cell migration and Bioinformatics.